Compare Reddit Inc (RDDT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Reddit (RDDT) trades at $156.49, up 2.44% today, showing strong momentum after recent earnings beats. The stock maintains a bullish technical outlook with support at $154 and resistance at $158. Fundamentally, the company demonstrates exceptional profitability with 91.44% gross margins and 31.35% net income margins, though valuation metrics remain elevated with a P/E of 36.39. Recent news highlights strategic partnerships and international expansion driving growth.

Outlook remains positive with analyst consensus at $202.52 (29% upside) and 65% buy ratings. Key opportunities include AI data licensing growth and international monetization, while risks involve competitive pressures and potential valuation compression given premium multiples. The company's transition to profitability and strong cash flow generation support continued expansion.

Recursion Pharmaceuticals (RXRX) trades at $3.95, down 7.49% today, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q2 2026 earnings miss after two consecutive beats, while maintaining negative profitability metrics with a -961.97% net income margin. Recent strategic partnerships with Tempus and Roche aim to expand the AI-driven drug discovery pipeline through 2028.

RXRX presents high-risk growth potential with strong analyst support (40% buy rating) but faces substantial financial challenges including persistent losses and negative cash flow from operations. The stock's investment case hinges on successful pipeline development and partnership monetization, though current valuation appears stretched at 37.14x sales given the lack of profitability.